PARP1 and prostate cancer: In prostate cancer models, BK002 (AJN combined with MFR) increased DNA damage and activated p-γH2A.X, promoting ubiquitination of pro-PARP, caspase9, and caspase3, leading to apoptosis in PC3 and DU145 cells.